Using an adapted protocol for the growth of tumor organoids36,37, we also tested the drug combination under 3D conditions, since mut KRAS lung cancer cells display a higher dependence on KRAS oncogene signaling in 3D cultures than 2D counterparts38,39. The gene discussed is KRAS; the disease is lung carcinoma.